MADISON BUTZ: Open Payments
NPI 1528768959 · GAINESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 38 payments from 9 companies in 2025. Trend: 2023 $223 · 2024 $850 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $210 |
| ABBVIE INC. | 13 | $204 |
| Lilly USA, LLC | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Exact Sciences Corporation | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: VRAYLAR, Rybelsus, Ozempic, Wegovy, AIRSUPRA, Kerendia, QULIPTA, MOUNJARO.
Industry payments across VA — which companies pay providers there.
